Literature DB >> 16022636

Fibrin sealant tissue adhesive--review and update.

William D Spotnitz1, Roshan Prabhu.   

Abstract

The field of surgical tissue adhesives is rapidly developing, with multiple products now available. Fibrin sealant, the first widely available tissue adhesive, continues to be used in traditional as well as in new and creative ways. The product is now fully mature as a hemostatic agent in cardiac, liver, and spleen surgery. It is also useful as a sealant in a variety of clinical applications, including procedures such as colonic anastomosis, as well as in seroma prevention following soft tissue dissection. Newer uses such as reduced suture vascular and intestinal anastomosis, fistula closure, surgery in patients with hemophilia, and laparoscopic/endoscopic procedures are being studied in both laboratory and clinical settings. The most recent additions to the capabilities of fibrin sealant include the use of this tissue adhesive as a slow-release drug delivery system and as a substrate for cellular growth and tissue engineering. This article will review the basis of fibrin sealant effectiveness and will also cover the recent developments in the rapidly evolving employment of this material.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16022636     DOI: 10.1615/jlongtermeffmedimplants.v15.i3.20

Source DB:  PubMed          Journal:  J Long Term Eff Med Implants        ISSN: 1050-6934


  22 in total

1.  Reduction of the closure time of postoperative enterocutaneous fistulas with fibrin sealant.

Authors:  Jorge Avalos-González; Eliseo Portilla-deBuen; Caridad Aurea Leal-Cortés; Abel Orozco-Mosqueda; María del Carmen Estrada-Aguilar; Gabriela Abigail Velázquez-Ramírez; Gabriela Ambriz-González; Clotilde Fuentes-Orozco; Aldo Emmerson Guzmán-Gurrola; Alejandro González-Ojeda
Journal:  World J Gastroenterol       Date:  2010-06-14       Impact factor: 5.742

2.  Interpenetrating collagen-fibrin composite matrices with varying protein contents and ratios.

Authors:  Shaneen L Rowe; Jan P Stegemann
Journal:  Biomacromolecules       Date:  2006-11       Impact factor: 6.988

3.  Rational design of hydrogels to enhance osteogenic potential.

Authors:  Soyon Kim; Min Lee
Journal:  Chem Mater       Date:  2020-11-05       Impact factor: 9.811

4.  Analysis of the hemostatic potential of modern topical sealants on arterial and venous anastomoses: an experimental porcine study.

Authors:  Hamidreza Fonouni; Arash Kashfi; Ali Majlesara; Oliver Stahlheber; Lukas Konstantinidis; Thomas W Kraus; Arianeb Mehrabi; Hani Oweira
Journal:  J Mater Sci Mater Med       Date:  2017-07-28       Impact factor: 3.896

5.  Synthesis and Characterization of Salicylic Acid-Based Poly(Anhydride-Ester) Copolymers.

Authors:  Robert C Schmeltzer; Kathryn E Uhrich
Journal:  J Bioact Compat Polym       Date:  2006-03       Impact factor: 1.756

Review 6.  Design strategies and applications of tissue bioadhesives.

Authors:  Mohammadreza Mehdizadeh; Jian Yang
Journal:  Macromol Biosci       Date:  2012-12-06       Impact factor: 4.979

7.  Thermogelling bioadhesive scaffolds for intervertebral disk tissue engineering: preliminary in vitro comparison of aldehyde-based versus alginate microparticle-mediated adhesion.

Authors:  C Wiltsey; T Christiani; J Williams; J Scaramazza; C Van Sciver; K Toomer; J Sheehan; A Branda; A Nitzl; E England; J Kadlowec; C Iftode; J Vernengo
Journal:  Acta Biomater       Date:  2015-01-30       Impact factor: 8.947

8.  Renal injury and the application of polysaccharide hemospheres: a laparoscopic experimental model.

Authors:  Mitchell R Humphreys; James E Lingeman; Colin Terry; Erik P Castle; Paul E Andrews; Matthew T Gettman; Mark H Ereth
Journal:  J Endourol       Date:  2008-06       Impact factor: 2.942

Review 9.  Sucrose-formulated octocog alfa: a review of its use in patients with haemophilia A.

Authors:  James E Frampton; Antona J Wagstaff
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 10.  Comparison of hemostatic agents used in vascular surgery.

Authors:  Krishna S Vyas; Sibu P Saha
Journal:  Expert Opin Biol Ther       Date:  2013-10-22       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.